Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preferences for antimuscarinic therapy for overactive bladder.
Swinburn P, Lloyd A, Ali S, Hashmi N, Newal D, Najib H. Swinburn P, et al. Among authors: ali s. BJU Int. 2011 Sep;108(6):868-73. doi: 10.1111/j.1464-410X.2010.09882.x. Epub 2010 Nov 24. BJU Int. 2011. PMID: 21105989 Review.
Willingness to pay for obesity pharmacotherapy.
Doyle S, Lloyd A, Birt J, Curtis B, Ali S, Godbey K, Sierra-Johnson J, Halford JC. Doyle S, et al. Among authors: ali s. Obesity (Silver Spring). 2012 Oct;20(10):2019-26. doi: 10.1038/oby.2011.387. Epub 2012 Feb 2. Obesity (Silver Spring). 2012. PMID: 22301901 Free article. Review.
Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971](1).
Trivedi D, Kirby M, Norman F, Przybytniak I, Ali S, Wellsted DM. Trivedi D, et al. Among authors: ali s. BJU Int. 2011 Dec;108(11):1850-4. doi: 10.1111/j.1464-410X.2011.10122.x. Epub 2011 Mar 3. BJU Int. 2011. PMID: 21371242 Clinical Trial.
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.
Ali S, Paracha N, Cook S, Giovannoni G, Comi G, Rammohan K, Rieckmann P, Sørensen PS, Vermersch P, Greenberg S, Scott DA, Joyeux A; CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) Study Group. Ali S, et al. Clin Drug Investig. 2012 Jan 1;32(1):15-27. doi: 10.2165/11593310-000000000-00000. Clin Drug Investig. 2012. PMID: 22017519 Clinical Trial.
13,320 results
You have reached the last available page of results. Please see the User Guide for more information.